Medical Technology - D-A-CH

D-A-CH

The Medical Technology market market in D-A-CH, consisting of Germany, Austria, and Switzerland, is expected to achieve a projected revenue of US$47.30bn by 2024.
Among the various markets within the market, the largest is Medical Devices, which is anticipated to reach a market volume of US$42.16bn in the same year.
Over the period of 2024-2029, the revenue is projected to exhibit a compound annual growth rate (CAGR) of 4.75%, leading to a market volume of US$59.65bn by 2029.
When compared globally, the United States is expected to generate the highest revenue, amounting to US$211.10bn in 2024.
Germany's medical technology market is thriving with a focus on innovative solutions for precision medicine and personalized healthcare.

Key regions: United States, Germany, China, Japan, France

Market

Region

Region comparison

Currency

Analyst Opinion

The Medical Technology market in D-A-CH, consisting of Germany, Austria, and Switzerland, is experiencing significant growth and development. Customer preferences in the Medical Technology market in D-A-CH are driven by the increasing demand for innovative healthcare solutions. Customers in this region value advanced medical technologies that can improve patient outcomes and enhance the efficiency of healthcare delivery. There is a growing preference for minimally invasive procedures, personalized medicine, and digital health solutions. Patients and healthcare providers in D-A-CH are increasingly seeking technologies that can enable early detection and prevention of diseases, as well as remote monitoring and telemedicine capabilities. Trends in the market indicate a shift towards digitalization and connectivity. The adoption of electronic health records, telemedicine platforms, and mobile health applications is on the rise. Medical technology companies in D-A-CH are investing in research and development to create innovative solutions that can address the evolving needs of the healthcare industry. There is a focus on developing technologies that can improve the diagnosis, treatment, and management of chronic conditions, such as cardiovascular diseases and diabetes. Additionally, there is a growing interest in artificial intelligence and machine learning applications in healthcare, which can enhance the accuracy and efficiency of medical diagnostics and decision-making. Local special circumstances in the D-A-CH region contribute to the development of the Medical Technology market. Germany, Austria, and Switzerland have well-established healthcare systems and high healthcare expenditure per capita. These countries have a strong emphasis on quality healthcare and are known for their advanced medical research and development capabilities. The presence of leading academic institutions, research centers, and medical device manufacturers in this region fosters innovation and collaboration. Furthermore, the aging population in D-A-CH creates a significant demand for medical technologies that can address age-related health issues and support independent living. Underlying macroeconomic factors also play a role in the growth of the Medical Technology market in D-A-CH. The stable economic conditions and high disposable income levels in these countries enable individuals and healthcare providers to invest in advanced medical technologies. The favorable regulatory environment and strong intellectual property protection in D-A-CH attract investment and support the development of new medical devices and technologies. Additionally, the increasing healthcare expenditure by governments and private insurers in the region further fuels the demand for medical technologies. In conclusion, the Medical Technology market in D-A-CH is witnessing growth and development driven by customer preferences for innovative healthcare solutions, trends towards digitalization and connectivity, local special circumstances such as advanced healthcare systems and aging population, and underlying macroeconomic factors including stable economic conditions and high healthcare expenditure. The market in this region is poised for further expansion as medical technology companies continue to invest in research and development to meet the evolving needs of the healthcare industry.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.